Krisha McCoy, MS
Pneumococcal disease is an infection caused by bacteria. It can lead to:
is spread by person-to-person contact.
There are 2 types of pneumococcal vaccines:
Adults 65 years old and older may receive PCV followed by PPSV. Ask your doctor if you should receive both vaccines.
The vaccines are made from inactivated bacteria. They are given by injection under the skin or into the muscle. The goal of getting a vaccine is that later, when you are exposed to the bacteria, you will not get sick from it.
The PCV is routinely given in 4 doses at 2, 4, 6, and 12-15 months. It can also be given to children with high-risk conditions. It is also recommended for all adults aged 65 years and older.
If your child has not been vaccinated or missed a dose, talk to their doctor. Depending on your child's age, additional doses may be needed. Also, an additional dose may be needed if your child:
The PPSV is given to adults aged 65 years and older.
PPSV is also given to anyone aged 2-64 years who have certain conditions, such as:
PPSV is also given to anyone aged 2-64 years who is taking a drug or treatment that lowers the body's ability to resist infection, such as:
The vaccine should be given at least 2 weeks before cancer treatment begins.
PPSV should also be given to any adult aged 19-64 years old who:
In some cases, a second dose of PPSV may be needed. For example, a second dose is recommended for people 65 and older who got their first dose before they turned 65 and it has been more than 5 years since that dose. A second dose is also recommended for people 2 through 64 who have:
When a second dose is given, it should be 5 years after the first dose.
Generally, all vaccines have a small risk of serious problems. Side effects of PCV include:
Acetaminophen is sometimes given to reduce pain and fever that may occur after getting a vaccine.
the medication at the time of the shot
may weaken the vaccine's effectiveness. Discuss the risks and benefits of taking acetaminophen with the doctor.
Half of the people who get the vaccine have mild side effects. However, developing the disease is much more likely to cause serious problems than getting the vaccine. Side effects may include:
Children who should not receive the vaccine are those who:
You should not receive the PPSV if you:
You can prevent pneumococcal disease if you:
In the event of an outbreak, all people who are eligible for a vaccine should receive it.
WHERE CAN I GET MORE INFORMATION?
Family Doctor—American Academy of Family Physicians
Vaccines & Immunizations
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention website. Available at:
http://www.cdc.gov/vaccines/schedules. Updated January 26, 2015. Accessed November 11, 2015.
Kobayashi M, Bennett NM, Gierke R, et al. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2015;64(34):944-947.
Pneumococcal conjugate vaccine. Centers for Disease Control and Prevention website. Available at:
http://www.cdc.gov/vaccines/hcp/vis/vis-statements/pcv13.pdf. Updated November 5, 2015. Accessed November 11, 2015.
Pneumococcal disease. Immunization Action Coalition website. Available at:
http://www.vaccineinformation.org/pneumococcal. Updated January 12, 2015. Accessed November 11, 2015.
Pneumococcal polysaccharide vaccine. Centers for Disease Control and Prevention website. Available at:
http://www.cdc.gov/vaccines/hcp/vis/vis-statements/ppv.pdf. Updated April 24, 2015. Accessed November 11, 2015.
Pneumococcal: understanding the disease. National Network for Immunization Information website. Available at:
http://www.immunizationinfo.org/vaccines/pneumococcal-disease. Accessed November 11, 2015.
Pneumococcal vaccination. Centers for Disease Control and Prevention website. Available at: http://www.cdc.gov/vaccines/vpd-vac/pneumo/default.htm?s_cid=cs_797. Updated July 21, 2015. Accessed November 11, 2015.
10/30/2009 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: Prymula R, Siegrist C, Chilbek R, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.
9/17/2010 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: Centers for Disease Control and Prevention. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).
MMWR Morb Mortal Wkly Rep.
1/7/2011 DynaMed's Systematic Literature Surveillance
Nuorti J, Whitney C, et al. Prevention of pneumococcal disease among infants and children—use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine.
MMWR Morb Mortal Wkly Rep. 2010;59(34):1102.
Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices.
Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).
MMWR Morb Mortal Wkly Rep.
Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices. Licensure of a 13-Valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children.
MMWR Recomm Rep. 2010;59(RR-11):1.
Last reviewed November 2015 by David L. Horn, MD
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.